ReviewCardiovascular endocrinology & metabolism2018

Mechanism of cardiovascular disease benefit of glucagon-like peptide 1 agonists.

Josh Reed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.